Close Menu

10X Genomics

 

10x Genomics, Inc. is an American company incorporated in 2012 that develops and manufactures integrated systems for whole genome sequencing, exome sequencing and single cell transcriptomics. Its headquarters are located in Pleasanton, California.

 

10X Genomics Company Profile  

 

President & CEO: Serge Saxonov

CEO photo:

 10X Genomics CEO photo - Serge Saxonov

Website: http://10xgenomics.com

Headquarters: Pleasanton, CA

10x Genomics employees: 101-250

Funding: $113M USD

Founded: 2012

Founders: Serge Saxonov, Ben Hindson


 

10x Genomics News 

The companies will each create products using Agilent's SureSelect target enrichment technology on 10x's Chromium platform.

The companies plan to combine Qiagen's sample technologies with 10x's microfluidics-based linked-read sequencing systems.

In a study published in Nature Biotechnology today, the researchers used the GemCode platform to haplotype a HapMap family trio, a cancer cell line, and a primary cancer.

Executives from the sequencing tech firms provided attendees with an update on recently launched products and platforms, and future technology developments.

Pacific Biosciences' launch of the Sequel instrument, Oxford Nanopore Technologies' MinIon instrument, and 10X Genomics' technology excited the market in 2015.

Bio-Rad brought a claim before the American Arbitration Association in 2014, alleging that three 10X Genomics founders breached certain contractual obligations.

The firm discussed its technology, the NIST data, and data from some early customers in a webinar it hosted this week.

Kapa will supply DNA library prep reagents for 10X's GemCode platform to enable a more streamlined workflow and higher quality sequencing data.

10X Genomics' GemCode platform

Several early-access customers presented results from the 10X technology at the meeting.

The plaintiffs accuse 10X, a synthetic long-read technology firm, of infringing six patents covering methods of conducting reactions within microfabricated substrates.

Pages

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.